Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype

Katsuyuki Namba, Kazuhito Naka, Hiromichi Dansako, Akito Nozaki, Masanori Ikeda, Yasushi Shiratori, Kunitada Shimotohno, Nobuyuki Kato

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

To clarify the mechanism underlying resistance to interferon (IFN) by the hepatitis C virus (HCV) in patients with chronic hepatitis, we attempted to develop an IFN-resistant HCV replicon from the IFN-sensitive 50-1 replicon established previously. By treating 50-1 replicon cells with a prolonged low-dose treatment of IFN-α and then transfecting the total RNA derived from the IFN-α-treated replicon cells, we successfully obtained four clones (named 1, 3, 4, and 5) of HCV replicon cells that survived against IFN-α (200 IU/ml). These cloned cells were further treated with IFN-α or IFN-β (increased gradually to 2000 or 1000 IU/ml, respectively). This led to four replicon cell lines (αR series) possessing the IFN-α-resistant phenotype and four replicon cell lines (βR series) possessing the IFN-β-resistant phenotype. Furthermore, we obtained an additional replicon cell line (αRmix) possessing the IFN-β-resistant phenotype by two rounds of prolonged treatment with IFN-α and RNA transfection as mentioned above. Characterization of these obtained HCV replicon cell lines revealed that the αR series were highly resistant to both IFN-α and IFN-β, although the αR series containing αRmix were only partially resistant to both IFN-α and IFN-β. Genetic analysis of these HCV replicons found one common amino acid substitution in the NS4B and several additional amino acid substitutions in the NS5A of the βR series, suggesting that these genetic alterations are involved in the IFN resistance of these HCV replicons. These newly established HCV replicon cell lines possessing IFN-resistant phenotypes are the first useful tools for understanding the mechanisms by which HCV acquires IFN resistance in vivo.

Original languageEnglish
Pages (from-to)299-309
Number of pages11
JournalBiochemical and Biophysical Research Communications
Volume323
Issue number1
DOIs
Publication statusPublished - Oct 8 2004

Fingerprint

Replicon
Viruses
Hepacivirus
Interferons
Cells
Phenotype
Cell Line
Amino Acid Substitution
Substitution reactions
RNA
Amino Acids

Keywords

  • Hepatitis C virus
  • Huh-7
  • Interferon resistance
  • Replicon

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology
  • Cell Biology

Cite this

Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. / Namba, Katsuyuki; Naka, Kazuhito; Dansako, Hiromichi; Nozaki, Akito; Ikeda, Masanori; Shiratori, Yasushi; Shimotohno, Kunitada; Kato, Nobuyuki.

In: Biochemical and Biophysical Research Communications, Vol. 323, No. 1, 08.10.2004, p. 299-309.

Research output: Contribution to journalArticle

Namba, Katsuyuki ; Naka, Kazuhito ; Dansako, Hiromichi ; Nozaki, Akito ; Ikeda, Masanori ; Shiratori, Yasushi ; Shimotohno, Kunitada ; Kato, Nobuyuki. / Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. In: Biochemical and Biophysical Research Communications. 2004 ; Vol. 323, No. 1. pp. 299-309.
@article{ca632605893045f48759e362a8602d53,
title = "Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype",
abstract = "To clarify the mechanism underlying resistance to interferon (IFN) by the hepatitis C virus (HCV) in patients with chronic hepatitis, we attempted to develop an IFN-resistant HCV replicon from the IFN-sensitive 50-1 replicon established previously. By treating 50-1 replicon cells with a prolonged low-dose treatment of IFN-α and then transfecting the total RNA derived from the IFN-α-treated replicon cells, we successfully obtained four clones (named 1, 3, 4, and 5) of HCV replicon cells that survived against IFN-α (200 IU/ml). These cloned cells were further treated with IFN-α or IFN-β (increased gradually to 2000 or 1000 IU/ml, respectively). This led to four replicon cell lines (αR series) possessing the IFN-α-resistant phenotype and four replicon cell lines (βR series) possessing the IFN-β-resistant phenotype. Furthermore, we obtained an additional replicon cell line (αRmix) possessing the IFN-β-resistant phenotype by two rounds of prolonged treatment with IFN-α and RNA transfection as mentioned above. Characterization of these obtained HCV replicon cell lines revealed that the αR series were highly resistant to both IFN-α and IFN-β, although the αR series containing αRmix were only partially resistant to both IFN-α and IFN-β. Genetic analysis of these HCV replicons found one common amino acid substitution in the NS4B and several additional amino acid substitutions in the NS5A of the βR series, suggesting that these genetic alterations are involved in the IFN resistance of these HCV replicons. These newly established HCV replicon cell lines possessing IFN-resistant phenotypes are the first useful tools for understanding the mechanisms by which HCV acquires IFN resistance in vivo.",
keywords = "Hepatitis C virus, Huh-7, Interferon resistance, Replicon",
author = "Katsuyuki Namba and Kazuhito Naka and Hiromichi Dansako and Akito Nozaki and Masanori Ikeda and Yasushi Shiratori and Kunitada Shimotohno and Nobuyuki Kato",
year = "2004",
month = "10",
day = "8",
doi = "10.1016/j.bbrc.2004.08.091",
language = "English",
volume = "323",
pages = "299--309",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype

AU - Namba, Katsuyuki

AU - Naka, Kazuhito

AU - Dansako, Hiromichi

AU - Nozaki, Akito

AU - Ikeda, Masanori

AU - Shiratori, Yasushi

AU - Shimotohno, Kunitada

AU - Kato, Nobuyuki

PY - 2004/10/8

Y1 - 2004/10/8

N2 - To clarify the mechanism underlying resistance to interferon (IFN) by the hepatitis C virus (HCV) in patients with chronic hepatitis, we attempted to develop an IFN-resistant HCV replicon from the IFN-sensitive 50-1 replicon established previously. By treating 50-1 replicon cells with a prolonged low-dose treatment of IFN-α and then transfecting the total RNA derived from the IFN-α-treated replicon cells, we successfully obtained four clones (named 1, 3, 4, and 5) of HCV replicon cells that survived against IFN-α (200 IU/ml). These cloned cells were further treated with IFN-α or IFN-β (increased gradually to 2000 or 1000 IU/ml, respectively). This led to four replicon cell lines (αR series) possessing the IFN-α-resistant phenotype and four replicon cell lines (βR series) possessing the IFN-β-resistant phenotype. Furthermore, we obtained an additional replicon cell line (αRmix) possessing the IFN-β-resistant phenotype by two rounds of prolonged treatment with IFN-α and RNA transfection as mentioned above. Characterization of these obtained HCV replicon cell lines revealed that the αR series were highly resistant to both IFN-α and IFN-β, although the αR series containing αRmix were only partially resistant to both IFN-α and IFN-β. Genetic analysis of these HCV replicons found one common amino acid substitution in the NS4B and several additional amino acid substitutions in the NS5A of the βR series, suggesting that these genetic alterations are involved in the IFN resistance of these HCV replicons. These newly established HCV replicon cell lines possessing IFN-resistant phenotypes are the first useful tools for understanding the mechanisms by which HCV acquires IFN resistance in vivo.

AB - To clarify the mechanism underlying resistance to interferon (IFN) by the hepatitis C virus (HCV) in patients with chronic hepatitis, we attempted to develop an IFN-resistant HCV replicon from the IFN-sensitive 50-1 replicon established previously. By treating 50-1 replicon cells with a prolonged low-dose treatment of IFN-α and then transfecting the total RNA derived from the IFN-α-treated replicon cells, we successfully obtained four clones (named 1, 3, 4, and 5) of HCV replicon cells that survived against IFN-α (200 IU/ml). These cloned cells were further treated with IFN-α or IFN-β (increased gradually to 2000 or 1000 IU/ml, respectively). This led to four replicon cell lines (αR series) possessing the IFN-α-resistant phenotype and four replicon cell lines (βR series) possessing the IFN-β-resistant phenotype. Furthermore, we obtained an additional replicon cell line (αRmix) possessing the IFN-β-resistant phenotype by two rounds of prolonged treatment with IFN-α and RNA transfection as mentioned above. Characterization of these obtained HCV replicon cell lines revealed that the αR series were highly resistant to both IFN-α and IFN-β, although the αR series containing αRmix were only partially resistant to both IFN-α and IFN-β. Genetic analysis of these HCV replicons found one common amino acid substitution in the NS4B and several additional amino acid substitutions in the NS5A of the βR series, suggesting that these genetic alterations are involved in the IFN resistance of these HCV replicons. These newly established HCV replicon cell lines possessing IFN-resistant phenotypes are the first useful tools for understanding the mechanisms by which HCV acquires IFN resistance in vivo.

KW - Hepatitis C virus

KW - Huh-7

KW - Interferon resistance

KW - Replicon

UR - http://www.scopus.com/inward/record.url?scp=4444246435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444246435&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2004.08.091

DO - 10.1016/j.bbrc.2004.08.091

M3 - Article

C2 - 15351737

AN - SCOPUS:4444246435

VL - 323

SP - 299

EP - 309

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -